Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 772 of 1,261

  1. AU 2013283318

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH [DE] · Granted Jan 22, 2015 · Expires Jan 17, 2035

    granted

  2. US 8937055

    Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action

    Takeda Pharmaceutical Company Limited · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  3. US 8936781

    Macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  4. US 8936650

    Mesh enclosed tissue constructs

    The Regents of the University of California · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  5. US 8937064

    Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  6. US 8936794

    Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  7. US 8937180

    Method for preparing a polymer conjugate

    Nektar Therapeutics · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  8. US 8937093

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  9. US 8937099

    N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

    SENTIENT LIFESCIENCES, INC. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  10. US 8937082

    Nilotinib salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  11. US 8937067

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  12. US 8937060

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  13. US 8936941

    Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  14. US 8937053

    Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  15. US 8937046

    Modulating the alternative complement pathway

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  16. US 8936787

    Peptides promoting lipid efflux

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  17. US 8936792

    Pseudomonas exotoxin a with reduced immunogenicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  18. US 8937178

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  19. US 2015017178

    Anti-CD26 Antibodies and Uses Thereof

    ADIENNE S R L S U [IT] · Granted Jan 15, 2015 · Expires Jan 10, 2035

    granted

  20. US 8932583

    Scaffolds for cell transplantation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  21. US 8933115

    Stabilized statin formulations

    Cumberland Pharmaceuticals Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  22. US 8933203

    Vault and vault-like carrier molecules

    The Regents of the University of California · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  23. US 8933059

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  24. US 8933080

    Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.